[GPI biosynthetic pathway as a target for antiprotozoan drugs].
Nagamune
Kisaburo
K
nagamune@biken.osaka-u.ac.jp
Kinoshita
Taroh
T
D000818:Animals; D000981:Antiprotozoal Agents; D015195:Drug Design; D017261:Glycosylphosphatidylinositols / Q000096:biosynthesis* / Q000737:chemistry / Q000502:physiology; D007891:Leishmania / Q000378:metabolism; D010961:Plasmodium / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D014346:Trypanosoma brucei brucei / Q000378:metabolism
D000981:Antiprotozoal Agents; D017261:Glycosylphosphatidylinositols